9 results match your criteria: "Manchester Head and Neck Centre[Affiliation]"
J Laryngol Otol
July 2024
Beatson West of Scotland Cancer Centre, Glasgow, Scotland, UK.
J Laryngol Otol
April 2024
Clinical Oncology, Ipswich Hospital, East Suffolk and North Essex NHS Foundation Trust, Ipswich, UK.
Front Neurol
April 2019
Manchester Centre for Audiology and Deafness, The University of Manchester, Manchester, United Kingdom.
This study sought to investigate whether the size of the target used in the horizontal vHIT has an effect on the saccade profile of healthy subjects, and to expand upon previous work linking age to the existence of small vHIT saccades. Forty eight participants were recruited between 18 and 77 years of age, with no history of vestibular, oculomotor or neurological conditions and a visual acuity of at least 0.3 LogMAR.
View Article and Find Full Text PDFBr J Oral Maxillofac Surg
February 2019
Manchester University NHS Foundation Trust, Manchester Head and Neck Centre, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL.
The Taser X26 (Axon) is a conducted energy device that is used by the police forces in the United Kingdom to deliver a high voltage shock that will disable a person. Injuries related to its use are uncommon but can be serious, the extent of the damage caused being related to the structures targeted and the length of deployment of the electrical charge. We describe a 15-year-old boy who had a penetrating midfacial injury after deployment of a Taser, the barb of which became embedded in the subtarsal region of his left cheek.
View Article and Find Full Text PDFClin Otolaryngol
June 2017
Department of Otolaryngology-Head and Neck Surgery, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.
Background: Systematic reviews comparing treatment of early glottic cancer with transoral surgery or radiotherapy demonstrate similar oncological outcomes. Most studies of 'early-stage' laryngeal cancer include Tis, T1a, T1b and T2 cases. The data are dominated by patients with T1 and Tis tumours, although extrapolating these results and applying them for T2 cases may be inappropriate.
View Article and Find Full Text PDFBr J Oral Maxillofac Surg
February 2017
Department of Oral and Maxillofacial Surgery, John Radcliffe Hospital, Oxford, OX3 9DU, UK.
Br J Oral Maxillofac Surg
December 2016
Department of Oral and Maxillofacial Surgery, Manchester Head and Neck Centre, Manchester Royal Infirmary, Manchester, UK.
Br J Oral Maxillofac Surg
May 2016
Department of Oral and Facial Surgery, Sunderland Royal Hospital, Sunderland, UK.
The appearance and function of the midface are crucial physiologically, psychologically, and aesthetically, and defects in the region can be devastating. Most of these defects are caused by operations for cancer, for which surgical access and rehabilitation can be challenging. Clinical evidence in midfacial ablative surgery is limited because differences between existing classifications do not allow a uniform approach to data recording, which makes comparison difficult.
View Article and Find Full Text PDFBr J Oral Maxillofac Surg
May 2016
Department of Oral and Maxillofacial Surgery, the Head and Neck Surgery Supra-regional Unit, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford, UK.
The SECONDI MAPZ(©) system is a new, simple, and logical classification of oncological defects of the midface that combines regional anatomy, 3-dimensional visualisation, and the hierarchy of functional priorities. In this paper, we provide clinical and radiographic examples of defects of varying complexity to illustrate the application of the system, to highlight its versatility, and to give practical clinical and radiological guidance on its use. We hope that its introduction will result in better communication of information, and the collection of more uniform data with which to compare outcomes, and ultimately will facilitate evidence-based practice in head and neck oncology.
View Article and Find Full Text PDF